Study Finds Radiation Therapy Administered Before Surgery Rarely Shrinks Retroperitoneal Sarcoma Tumors - Summary - MDSpire

Study Finds Radiation Therapy Administered Before Surgery Rarely Shrinks Retroperitoneal Sarcoma Tumors

According to new research from Fox Chase Cancer Center, radiation therapy administered before surgery rarely produces favorable responses in patients with retroperitoneal sarcoma (RPS), a rare and aggressive cancer that forms in the abdomen. The study reinforces findings from a major international clinical trial and suggests that, due to ineffectiveness, radiation should not be used to shrink tumors before surgery.

  • By

  • January 14, 2026

  • 4 min

Share

Objective:

To evaluate the effectiveness of pre-surgical radiation therapy in shrinking retroperitoneal sarcoma tumors.

Key Findings:
  • Only 1 patient (4.5%) experienced meaningful tumor shrinkage.
  • 77.3% of patients showed minimal change in tumor size.
  • 18.2% of patients experienced tumor growth during radiation therapy.
  • No reduction in surgical complexity or operative outcomes was observed.
Interpretation:

The study reinforces that pre-surgical radiation does not improve outcomes for retroperitoneal sarcoma patients and may delay necessary surgery.

Limitations:
  • Small sample size may limit generalizability.
  • Findings may not apply to all patient demographics or tumor characteristics.
Conclusion:

Skipping preoperative radiation and proceeding directly to surgery is recommended for most patients with retroperitoneal sarcoma.

Original Source(s)

Study Finds Radiation Therapy Administered Before Surgery Rarely Shrinks Retroperitoneal Sarcoma Tumors

  • by

  • January 14, 2026

Related Content

The role of NAD+ metabolic reprogramming in colorectal cancer chemoresistance: mechanistic insights, clinical translation challenges and opportunities

Artificial intelligence for optimization of immunotherapy: current applications and transformative potential

PD-1 inhibitor combined with chemoradiotherapy in two cases of ovarian cancer brain metastases: a case report